DIEBOLD NIXDORF, Inc
- Stock
- Ticker DBD
- ISIN US2536512021
- NYSE
Performance, volatility and drawdowns of DIEBOLD NIXDORF, Inc since 08/2023, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $20,195. Global equities (VT): $15,235.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −44.6% in 11/2026, measured from the peak in 07/2026. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 989 | 841 | 915 | 945 | 1,104 | 892 | 931 | 994 |
| Gross profit | 232 | 202 | 234 | 245 | 280 | 213 | 240 | 247 |
| Operating income | 41 | 30 | 56 | 74 | 82 | 33 | 57 | 39 |
| EBITDA | 79 | 64 | 65 | 82 | 113 | 64 | 63 | 46 |
| Net income | 5.6 | -8.3 | 12 | 41 | 50 | 5.0 | 16 | 6.6 |
| Earnings per share | 0.15 | -0.22 | 0.33 | 1.11 | 1.34 | 0.14 | 0.44 | 0.19 |
| Balance sheet | ||||||||
| Total assets | 3,544 | 3,626 | 3,740 | 3,724 | 3,854 | 3,830 | 3,737 | 3,663 |
| Liabilities | 2,605 | 2,635 | 2,635 | 2,611 | 2,750 | 2,804 | 2,760 | 2,719 |
| Equity | 930 | 984 | 1,097 | 1,107 | 1,100 | 1,023 | 969 | 936 |
| Cash | 296 | 307 | 279 | 246 | 369 | 359 | 282 | 185 |
| Long-term debt | 927 | 929 | 931 | 934 | 939 | 939 | 943 | 949 |
| Cash flow | ||||||||
| Operating cash flow | 196 | 16 | 30 | 37 | 218 | 32 | -14 | -47 |
| Free cash flow | 196 | 16 | 30 | 37 | 218 | 32 | -14 | -47 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +57.7%, weakest 2024 at +48.7%. 2 of 2 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 28 Oct 2026 | $0.19 |
| 29 Jul 2026 | $0.44 |
| 30 Apr 2026 | $0.14 |
| 12 Feb 2026 | $1.34 |
| 5 Nov 2025 | $1.11 |
| 6 Aug 2025 | $0.33 |
| 7 May 2025 | −$0.22 |
| 25 Feb 2025 | $0.15 |
| 7 Nov 2024 | −$0.60 |
| 7 Aug 2024 | $0.40 |
| 2 May 2024 | −$0.39 |
| 9 Aug 2023 | −$8.46 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.6bn
- Market cap in trading currency
- $1.74bn
- Enterprise value
- $2.51bn
- P/E
- 24.6
- P/S
- 0.44
- P/B
- 1.86
- EV/Sales
- 0.64
- EV/EBITDA
- 8.8
- Earnings yield
- 4.1%
- FCF yield
- 10.8%
Results (last four quarters)
- Revenue
- $3.92bn
- Gross profit
- $980m
- EBITDA
- $286m
- Net income
- $76.7m
- Earnings per share
- $2.11
- Revenue per share
- $116.75
- Revenue growth
- +5.2%
- Earnings growth
- −83.9%
Profitability
- Gross margin
- 25.0%
- Operating margin
- 5.4%
- Net margin
- 2.0%
- Return on equity
- 7.5%
- Return on assets
- 2.1%
Balance sheet and cash flow
- Cash
- $185m
- Cash per share
- $5.51
- Financial debt
- $949m
- Debt/equity %
- 101
- Current ratio
- 1.27
- Book value per share
- $27.87
- Operating cash flow
- $188m
- Free cash flow
- $188m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 33.6m
- Volume
- 515,330
- Avg. volume 3 months
- 292,249
- Relative volume
- 1.8
Price and technicals
- Price
- $51.86
- 1 day
- +3.2%
- 52-week high
- $90.75
- 52-week low
- $50.27
- Distance to 52-week high
- −42.9%
- Distance to 52-week low
- +3.2%
- Distance to 50-day line
- −15.7%
- Distance to 200-day line
- −29.8%
- RSI (14)
- 33
- Volatility 1M
- 64.4%
Performance
- 1 week
- −5.8%
- 1 month
- −25.1%
- 3 months
- −24.6%
- 6 months
- −30.2%
- YTD
- −23.6%
- 1 year
- −16.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has DBD performed since 08/2023?
$10,000 grew to $24,121 by 20 Nov 2026, which is +30.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is DBD?
Volatility was 37.4% per year, measured on monthly returns. The largest decline from a peak was −44.6%, with the low in 11/2026.
How does DBD compare with a broad equity ETF?
Over the same period Global equities (VT) returned +14.7% per year at 13.1% volatility, DBD returned +30.9% at 37.4%. The correlation of monthly returns was 0.52; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.